Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors

Oncolytic virus (OV) is a new therapeutic strategy for cancer treatment. OVs can selectively infect and destroy cancer cells, and therefore act as an in situ cancer vaccine by releasing tumor-specific antigens. Moreover, they can remodel the tumor microenvironment toward a T cell-inflamed phenotype...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Chang-Myung, Chon, Hong Jae, Kim, Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589893/
https://www.ncbi.nlm.nih.gov/pubmed/33086754
http://dx.doi.org/10.3390/ijms21207743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589893/
https://www.ncbi.nlm.nih.gov/pubmed/33086754
http://dx.doi.org/10.3390/ijms21207743

Ejemplares similares